CVS Health price target raised to $74 from $58 at RBC Capital
RBC Capital analyst Ben Hendrix raised the firm’s price target on CVS Health (CVS) to $74 from $58 and keeps an Outperform ...
CyberArk price target raised to $481 from $410 at RBC Capital
RBC Capital raised the firm’s price target on CyberArk (CYBR) to $481 from $410 and keeps an Outperform rating on the shares. The company posted a strong quarter with all metrics and initial 2025 ...
Finbold | Finance in Bold2h
2 AI stocks to avoid buying for now
Although the outlook on AI is widely positive, not all equities in the space are poised for success, as several headwinds ...
Hosted on MSN5h
NextEra Energy’s Reliance on Government Policies: A Double-Edged Sword for Clean Energy Growth
NextEra Energy Inc. (NEE) has disclosed a new risk, in the Manufacturing category. NextEra Energy Inc. faces significant ...
Hosted on MSN5h
Graftech Intl’s Price Hike Gamble: Will Aggressive Strategy Threaten Market Share and Financial Health?
Graftech Intl (EAF) has disclosed a new risk, in the Corporate Activity and Growth category. Graftech Intl faces a significant business risk as it ...
Mullen Automotive trading halted, news pending
EST Mullen Automotive (MULN) trading halted, news pendingMaximize Your Portfolio with Data Driven Insights:Leverage the power of ...
AtriCure files automatic mixed securities shelf
EST AtriCure (ATRC) files automatic mixed securities shelfMaximize Your Portfolio with Data Driven Insights:Leverage the power of ...